Finance

Lists
Why is CI up 2,71%?
Dive Deeper
CI:NYSE
Cigna Group
USD 306,60
+2,71%
(+8,10) 1D
USD 305,00
-0,52% (-1,60)
After hours
Closed: 20 Okt., 16:00:06 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CI...
Open
USD 302,00
High
USD 307,00
Low
USD 300,86
Mkt. cap
81,02 mjd
Avg. vol.
1,59 m
Volume
1,44 m
Dividend
2,04%
Quarterly dividend
USD 1,56
Ex-dividend date
08 Sep. 2026
P/E ratio
12,71
52-wk high
USD 311,34
52-wk low
USD 239,51
EPS
USD 24,13
Beta
0,29
Shares outstanding
264,24 m
No. of employees
67 k
Open
USD 302,00
High
USD 307,00
Low
USD 300,86
Mkt. cap
81,02 mjd
Avg. vol.
1,59 m
Volume
1,44 m
Dividend
2,04%
Quarterly dividend
USD 1,56
Ex-dividend date
08 Sep. 2026
P/E ratio
12,71
52-wk high
USD 311,34
52-wk low
USD 239,51
EPS
USD 24,13
Beta
0,29
Shares outstanding
264,24 m
No. of employees
67 k
News stories
From web sources and news partners
Profile
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups. Cigna is incorporated in Delaware. The company ranked No. 15 in the 2023 Fortune 500 list of the largest U.S. corporations by total revenue, and the company took 68th place in the 2023 Forbes Global 2000 ranking. It has been embroiled in controversies, including engaging in automatic denials of insurance claims without reviewing them. Wikipedia
About Cigna Group
CEO-
Employees66,7 k
Founded1792
HeadquartersBloomfield, Connecticut, Verenigde State van Amerika
SectorHealth care provider
Website-
Analyst ratings
Based on 19 analysts giving stock ratings to CI in the past 3 months
Buy
Buy
13
Hold
6
Sell
0
12-month forecast
Based on 19 Wall Street analysts offering 12 month price targets for CI in the last 3 months.
Highest
Current USD 306,60
USD 387,00 (+26,22%)
Average
USD 338,89 (+10,53%)
Lowest
USD 290,00 (-5,41%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ben Hendrix
RBC Capital
Buy
Maintained
USD 337,00
+9,9%
10/07/2026
Lance Wilkes
Bernstein
Buy
Maintained
USD 387,00
+26,2%
10/05/2026
David S Macdonald
Truist Financial
Buy
Reiterated
USD 350,00
+14,2%
10/02/2026
Jessica Tassan
Piper Sandler
Buy
Maintained
USD 370,00
+20,7%
10/02/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
USD 290,00
-5,4%
10/01/2026
Unknown Analyst
Leerink Partners
Hold
Reiterated
USD 300,00
-2,2%
10/01/2026
Michael Wiederhorn
Oppenheimer
Buy
Maintained
USD 365,00
+19%
10/01/2026
Charles Rhyee
TD Cowen
Buy
Maintained
USD 338,00
+10,2%
09/30/2026
Stephen Baxter
Wells Fargo
Hold
Maintained
USD 307,00
+0,1%
09/30/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
USD 378,00
+23,3%
10/01/2026
Andrew Mok CFA
Barclays
Hold
Maintained
USD 310,00
+1,1%
10/01/2026
Erin Wright
Morgan Stanley
Buy
Maintained
USD 361,00
+17,7%
09/29/2026
David Windley
Jefferies
Hold
Downgraded
USD 307,00
+0,1%
08/03/2026
Scott Fidel
Goldman Sachs
Buy
Maintained
USD 352,00
+14,8%
08/02/2026
Parker Snure
Raymond James
Buy
Maintained
USD 320,00
+4,4%
08/03/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
-
-
07/30/2026
George Hill
Deutsche Bank
Hold
Maintained
USD 305,00
-0,5%
07/31/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
USD 365,00
+19%
07/31/2026
Jailendra Singh
Truist Financial
Buy
Reiterated
USD 350,00
+14,2%
07/31/2026
Michael Ha
Robert W. Baird
Buy
Maintained
USD 362,00
+18,1%
07/31/2026
Jason Cassorla
Guggenheim
Buy
Maintained
USD 361,00
+17,7%
07/30/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
USD 340,00
+10,9%
06/08/2026
A.J. Rice
UBS
Buy
Maintained
USD 400,00
+30,5%
05/22/2026
Unknown Analyst
Cantor Fitzgerald
Buy
Reiterated
USD 340,00
+10,9%
04/30/2026
Sarah James
Cantor Fitzgerald
Buy
Reiterated
USD 340,00
+10,9%
04/30/2026
Joanna Gajuk
Bank of America Securities
Buy
Maintained
USD 378,00
+23,3%
04/13/2026
Kevin Caliendo
UBS
Buy
Maintained
USD 375,00
+22,3%
02/09/2026
Last report
30 Jul. 2026
Fiscal period
Q2 2026
USD 7,78 / USD 7,60
+2,37%beat
Revenue / Est. (USD)
71,67 mjd / 70,18 mjd
+2,12%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
69,75 mjd
72,47 mjd
68,49 mjd
71,67 mjd
Cost of goods sold
63,37 mjd
66,06 mjd
62,02 mjd
65,13 mjd
Cost of revenue
63,37 mjd
66,06 mjd
62,02 mjd
65,13 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,15 mjd
3,40 mjd
2,33 mjd
3,29 mjd
Operating expense
3,59 mjd
3,86 mjd
2,72 mjd
3,68 mjd
Total operating expenses
66,96 mjd
69,91 mjd
64,74 mjd
68,81 mjd
Operating income
2,79 mjd
2,56 mjd
3,75 mjd
2,86 mjd
Other non operating income
16,00 m
-62,00 m
-357,00 m
3,00 m
EBT including unusual items
2,30 mjd
1,82 mjd
2,27 mjd
2,26 mjd
EBT excluding unusual items
2,44 mjd
2,20 mjd
3,40 mjd
2,50 mjd
Income tax expense
322,00 m
543,00 m
409,00 m
382,00 m
Effective tax rate
14,03%
29,88%
18,02%
16,93%
Other operating expenses
-
-
-
-
Net income
1,87 mjd
1,23 mjd
1,65 mjd
1,66 mjd
Net profit margin
2,68%
1,70%
2,41%
2,32%
Earnings per share
7,83
8,08
7,79
7,78
Interest and investment income
-
-
-
-
Interest expense
-363,00 m
-300,00 m
-
-359,00 m
Net interest expenses
-363,00 m
-300,00 m
-
-359,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
3,49 mjd
3,28 mjd
4,40 mjd
3,51 mjd
Gain or loss from assets sale
-38,00 m
66,00 m
-11,00 m
-6,00 m
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme